L-Carnitine From Tartrate vs Acetyl-L-Carnitine: Reading SperBalan’s 408 mg Label
TL;DR:
- Start with the verified SperBalan label, daily serving and warning language.
- Use the three cited scientific sources as context; do not convert them into a finished-product medical claim.
- Keep suitability conditional on the complete formula, current label and individual professional guidance.
Editorial answer: SperBalan’s verified current label declares 408 mg of L-carnitine in the recommended daily serving of two capsules and identifies L-carnitine tartrate as its source. That wording does not mean the formula contains 408 mg of the tartrate ingredient, and it does not identify acetyl-L-carnitine. A research paper becomes relevant only after its administered form, amount, co-intervention, population, duration and endpoint have been checked.
This is a source-form and study-transfer audit, not a claim that one carnitine form is universally better. It also makes no reproductive, fertility, testosterone, medical or finished-product outcome claim. The aim is narrower: read the panel literally, keep chemically distinct names separate and avoid importing results from a materially different protocol.
Commerce status is a separate question. On 4 September 2026, the France product record was ACTIVE, its canonical page returned direct HTTP 200 and the page displayed €30. The mapped variant had zero inventory and storefront availability was false, so nothing below is a purchase invitation or stock promise.
Table of Contents
- Read the 408 mg Line Literally
- Separate L-Carnitine, Tartrate, and ALC
- Audit the First Human Study
- Compare Two Tartrate Protocols
- Do Not Match Numbers Without Units
- Retain the Complete Label Context
- Keep Warnings and Commerce Separate
- Use a Six-Field Transfer Check
Key Takeaways
| Question | Verified answer | Boundary |
|---|---|---|
| What does 408 mg describe? | Declared L-carnitine per two capsules | Not the stated mass of L-carnitine tartrate |
| What does “from tartrate” mean? | L-carnitine tartrate is the named source | It is not acetyl-L-carnitine |
| Did the papers test SperBalan? | No | They used different forms, amounts, contexts and endpoints |
| Can a gram value be compared directly? | Only after the reported substance and serving are aligned | Active amount and source-ingredient mass are not interchangeable |
| Is the product available? | The record and canonical page were active | The mapped variant was unavailable |
Read the 408 mg Line Literally
The controlling English label and current SperBalan product information set the reporting unit at two capsules per day. Within that serving, the line reads L-carnitine, from L-carnitine tartrate, 408 mg. Its grammar matters: L-carnitine is the declared active entry, L-carnitine tartrate identifies the source and 408 mg is attached to L-carnitine.
The panel does not provide a separate mass for the tartrate source. It therefore does not support rewriting the line as “408 mg L-carnitine tartrate,” calculating an undisclosed source weight or converting the declaration into an amount of another derivative. The defensible statement is simply that two capsules declare 408 mg L-carnitine from L-carnitine tartrate.
A broader SperBalan label guide explains the complete panel. This article asks a different question: what happens when a reader encounters L-carnitine tartrate or acetyl-L-carnitine in a paper and tries to map that intervention back to this one label line?
Separate L-Carnitine, Tartrate, and ALC
Three names can appear in the same research search without describing the same administered material. L-carnitine is the substance declared on the SperBalan panel. L-carnitine tartrate is its named source in this formula. Acetyl-L-carnitine, often abbreviated ALC, is a different derivative and is not listed on the verified label.
The distinction is not a ranking. A different derivative may be selected for a different research question, delivery context or measured endpoint. What matters for transfer is whether the study administered the same material as the product, not whether related carnitine names appeared in the abstract.
A single-dose pharmacokinetic study in 12 healthy volunteers illustrates the risk. Researchers administered 2 g of liquid L-carnitine once, then measured L-carnitine, ALC and propionyl-L-carnitine in plasma and urine. ALC was a measured analyte after L-carnitine administration; the study did not administer SperBalan, L-carnitine tartrate or an ALC supplement.
That design can inform a discussion of related circulating forms after a particular 2 g liquid exposure. It cannot establish that the three names are interchangeable, that 408 mg from a tartrate source behaves the same way or that a measured metabolite is present as a declared ingredient in the finished formula.
Audit the First Human Study
A second paper is closer in one respect because it used L-carnitine L-tartrate. The balanced placebo-controlled crossover study enrolled 10 healthy, active men who used 3 g of L-carnitine L-tartrate daily for three weeks, with a one-week washout. Its stated purpose was to examine complete blood counts and circulating clinical-chemistry markers, including measures related to liver and renal function.
The investigators reported no statistically significant differences between the supplement and placebo conditions for the measured variables. That finding stays inside a small, short-duration safety-marker protocol in healthy active men. It is not evidence for a product benefit, does not establish every dimension of safety and does not test 408 mg of declared L-carnitine inside SperBalan’s eight-active formula.
Even the amount cannot be matched by placing “3 g” beside “408 mg.” The paper reports grams of L-carnitine L-tartrate, while the product label attaches 408 mg to L-carnitine from that source. Without a source-mass declaration on the product panel, the two figures do not share the same denominator.
Compare Two Tartrate Protocols
The third randomized double-blind human intervention also used L-carnitine L-tartrate, but its design was different again. Fourteen healthy male volunteers were assigned to 80 g carbohydrate alone or 2 g L-carnitine L-tartrate with 80 g carbohydrate, taken twice daily for 24 weeks. The researchers used muscle biopsies and exercise testing to examine muscle carnitine and exercise-metabolism endpoints.
This was a prolonged form-plus-carbohydrate protocol with a total of two daily doses, a healthy exercise population and tightly specified laboratory endpoints. It was not an isolated 408 mg label-line test. It did not use SperBalan, did not reproduce the complete formula and did not examine a reproductive or fertility outcome.
| Transfer field | SperBalan label | Three cited studies |
|---|---|---|
| Material | L-carnitine from L-carnitine tartrate | Liquid L-carnitine or L-carnitine L-tartrate |
| Declared amount | 408 mg L-carnitine per two capsules | 2 g once, 3 g daily, or 2 g twice daily as described by each paper |
| Co-intervention | Seven other active entries | None in two studies; 80 g carbohydrate per dose in one |
| Population | No finished-product trial population | Small groups of healthy or healthy active adults |
| Duration | Daily label serving | Single dose, three weeks or 24 weeks |
| Endpoint | No product outcome established | Pharmacokinetics, safety markers, or muscle and exercise measures |
The table shows why sharing a word such as “carnitine” or “tartrate” is only the beginning. Every other design field can still block transfer. None of these studies proves an outcome for the current product, and none should be converted into a capsule target.
Do Not Match Numbers Without Units
A credible comparison preserves both the number and what the number measures. The 408 mg panel value is declared L-carnitine per two capsules. The gram values in the tartrate papers describe the administered L-carnitine L-tartrate material. The single-dose pharmacokinetic paper instead administered liquid L-carnitine.
Those are not three versions of one common scale. Converting between an active declaration and source-ingredient mass would require composition information that is not supplied by the current product label. A larger-looking study number also does not become a recommendation. Research amounts belong to their protocols, populations and endpoints.
This rule protects against a second error: treating a measured ALC concentration as an ALC ingredient dose. In the first study, ALC was measured after free L-carnitine was given. The paper does not place acetyl-L-carnitine on SperBalan’s label and does not turn the tartrate source into ALC.
Retain the Complete Label Context
The daily serving is not a single-ingredient intervention. Alongside 408 mg L-carnitine from L-carnitine tartrate, the verified panel declares 230 mg maritime pine bark extract, 100 mg coenzyme Q10 as ubiquinone, 100 mg vitamin C, 15 mg zinc, 50 micrograms selenium, 5 mg black-pepper extract and 3.5 mg vitamin B6.
| Label entry | Amount per two capsules | Source detail retained here |
|---|---|---|
| L-carnitine | 408 mg | From L-carnitine tartrate |
| Maritime pine bark extract | 230 mg | No additional marker inferred |
| Coenzyme Q10 | 100 mg | Ubiquinone |
| Vitamin C | 100 mg | No outcome assigned |
| Zinc | 15 mg | No outcome assigned |
| Selenium | 50 micrograms | No outcome assigned |
| Black-pepper extract | 5 mg | No absorption claim inferred |
| Vitamin B6 | 3.5 mg | No outcome assigned |
Existing articles separately examine the 100 mg ubiquinone line and the selenium entry and its evidence boundaries. Their ingredient-specific discussions should not be imported into the carnitine analysis. Likewise, no wording associated with zinc, selenium or vitamin B6 can be reassigned to L-carnitine or used as proof of a complete-formula result.
Keep Warnings and Commerce Separate
The verified label reserves the product for adults, advises against use during pregnancy or breastfeeding and directs people taking medication to consult a doctor or pharmacist. The recommended daily dose should not be exceeded. A food supplement does not replace a varied, balanced diet and healthy lifestyle, and the package should be kept out of reach of young children.
No named allergen or free-from statement was identified in the controlling source. That absence cannot be rewritten as “allergen-free.” A reader with an allergy, medication question, pregnancy or breastfeeding consideration should use the current physical package and appropriate professional guidance rather than an inference from silence.
Shopify status also requires literal reading. ACTIVE meant that the France catalog record and canonical PDP were live at the check. It did not mean the variant was purchasable: inventory was zero, the inventory policy was deny and storefront availability was false. The displayed €30 price is dated context only and must be rechecked; it is not an offer in this article.
Use a Six-Field Transfer Check
- Declared form: distinguish L-carnitine, its tartrate source and acetyl-L-carnitine.
- Declared amount: retain 408 mg as L-carnitine per two capsules.
- Co-intervention: record the complete product matrix or study combination.
- Population: identify who was studied instead of generalizing to every reader.
- Duration: separate a single dose, three-week exposure and 24-week protocol.
- Endpoint: do not substitute pharmacokinetics, laboratory safety markers or exercise measures for a finished-product outcome.
The conclusion is precise. SperBalan declares 408 mg L-carnitine from L-carnitine tartrate per two capsules; it does not list acetyl-L-carnitine or disclose 408 mg as the tartrate-source mass. The three human papers demonstrate why related terminology is insufficient for transfer. Form, amount, co-intervention, population, duration and endpoint must all be reconstructed before a study can supply context, and none of the cited protocols tested SperBalan or establishes an outcome for its complete formula.
Frequently Asked Questions
What exactly does the SperBalan label declare for L-carnitine?
The verified label declares 408 mg of L-carnitine in the recommended daily serving of two capsules and says that it comes from L-carnitine tartrate. The line does not state that 408 mg is the mass of the tartrate source.
Is L-carnitine from tartrate the same as acetyl-L-carnitine?
No. L-carnitine tartrate is the source named for the label’s L-carnitine amount, while acetyl-L-carnitine is a different carnitine derivative. SperBalan’s verified label does not list acetyl-L-carnitine.
Did any of the three cited studies test SperBalan or its 408 mg label amount?
No. They used 2 g liquid L-carnitine once, 3 g L-carnitine L-tartrate daily for three weeks, or 2 g L-carnitine L-tartrate with 80 g carbohydrate twice daily for 24 weeks. None tested SperBalan, its two-capsule serving or its complete formula.
Can wording associated with zinc, selenium or vitamin B6 be assigned to L-carnitine?
No. Each label entry must keep its own identity and evidence boundary. A statement connected with one nutrient cannot be transferred to L-carnitine or promoted as a proven outcome of the complete product.
Is SperBalan currently available to purchase?
At the 4 September 2026 check, Shopify classified the France product as ACTIVE, its canonical page returned HTTP 200 and the page displayed €30. The mapped variant nevertheless had zero inventory, an inventory policy of deny and storefront availability false, so this guide makes no purchase or stock promise.
Recommended
- SperBalan Label Guide: Forms, Daily Dose, and Claim Boundaries
- SperBalan CoQ10 Ubiquinone 100 mg: A Buyer Label Guide
- SperBalan Selenium: A Label and Evidence-Boundary Guide
- Review the current SperBalan product information
Our research and formulas have been recognized by leading media outlets such as Marie Claire.
Scientific References
- Cao et al. (2009): single-dose pharmacokinetic study in 12 healthy volunteers after 2 g liquid L-carnitine, measuring plasma and urine L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine
- Rubin et al. (2001): balanced placebo-controlled crossover study in 10 healthy active men using 3 g L-carnitine L-tartrate daily for three weeks and assessing hematology and clinical chemistry
- Wall et al. (2011): randomized double-blind study in 14 healthy men using 2 g L-carnitine L-tartrate with 80 g carbohydrate twice daily for 24 weeks and measuring muscle and exercise endpoints
These statements have not been evaluated by the Food and Drug Administration. BioEssentials products are food supplements intended to support general wellness and daily nutritional needs. They are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before starting any new supplement if you are pregnant, breastfeeding, taking medication, or managing a health condition.
